Katharine L Chu Selected Research

Katharine L Chu Research Topics

Disease

13	Pain (Aches) 10/2018 - 10/2002
11	Hyperalgesia 06/2014 - 10/2002
5	Neuralgia (Stump Neuralgia) 06/2014 - 12/2003
4	Inflammation (Inflammations) 08/2012 - 10/2002
3	Chronic Pain 06/2014 - 03/2008
2	Wounds and Injuries (Trauma) 02/2018 - 11/2004
1	Neoplasms (Cancer) 01/2018
1	Fatigue 01/2018
1	Osteoarthritis 07/2013
1	Hypersensitivity (Allergy) 10/2010
1	Nociceptive Pain 10/2010
1	Acute Pain 10/2010
1	Ganglion Cysts (Ganglion) 01/2006
1	Peripheral Nerve Injuries 12/2003

Drug/Important Bio-Agent (IBA)

9	Freund's AdjuvantIBA 06/2014 - 11/2004
4	CarrageenanIBA 06/2014 - 10/2002
4	TRPV1 receptorIBA 03/2012 - 10/2003
3	Iodoacetic AcidIBA 02/2018 - 10/2010
3	Analgesics (Analgesic Drugs)IBA 04/2014 - 10/2010
3	A-889425IBA 03/2012 - 12/2008
2	N2- methyl- N- ((2- (4- (trifluoromethyl)phenyl)octahydrocyclopenta(c)pyrrol- 4- yl)leucinamideIBA 04/2014 - 01/2014
2	A-317491IBA 08/2012 - 12/2003
2	Capsaicin (Zostrix)FDA Link 10/2010 - 10/2003
1	PlasticsIBA 02/2018
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 02/2018
1	depatuxizumab mafodotinIBA 01/2018
1	ErbB Receptors (EGF Receptor)IBA 01/2018
1	Immunoconjugates (Immunoconjugate)IBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Cytotoxins (Cytolysins)IBA 01/2018
1	T-Type Calcium Channels (T-Type Calcium Channel)IBA 06/2014
1	4- chloro- 2- fluoro- N- (2- fluorophenyl)- 5- (hexahydropyrrolo(1,2- a)pyrazin- 2(1H)- ylcarbonyl)benzenesulfonamideIBA 06/2014
1	Mitogen-Activated Protein Kinase 3IBA 04/2014
1	Biomarkers (Surrogate Marker)IBA 04/2014
1	Histamine (Histamine Dihydrochloride)FDA Link 10/2012
1	A 967079IBA 05/2011
1	Pharmaceutical PreparationsIBA 05/2011
1	allyl isothiocyanateIBA 05/2011
1	TRPV Cation ChannelsIBA 05/2011
1	ABT 102IBA 05/2011
1	TRPA1 Cation ChannelIBA 05/2011
1	fasudil (AT 877)IBA 10/2010
1	rho-Associated KinasesIBA 10/2010
1	CationsIBA 09/2008
1	Sodium Channel BlockersIBA 03/2008
1	A 803467IBA 03/2008
1	furanIBA 03/2008
1	1- isoquinolin- 5- yl- 3- (4- trifluoromethyl- benzyl)- ureaIBA 01/2006
1	salicylhydroxamic acid (SHAM)IBA 11/2004
1	NucleotidesIBA 12/2003
1	capsazepineIBA 10/2003
1	Neurotransmitter Agents (Neurotransmitter)IBA 10/2002
1	Adenosine KinaseIBA 10/2002
1	N(6)-cyclopentyladenosineIBA 10/2002
1	Purinergic P1 Receptor AgonistsIBA 10/2002
1	Adenosine-5'-(N-ethylcarboxamide) (NECA)IBA 10/2002
1	NucleosidesIBA 10/2002
1	Adenosine (Adenocard)FDA LinkGeneric 10/2002
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 10/2002
1	2- (4- (2- carboxyethyl)phenethylamino)- 5'- N- ethylcarboxamidoadenosineIBA 10/2002

Therapy/Procedure

4	Ligation 01/2014 - 12/2003
3	Injections 01/2017 - 12/2003
2	Oral Administration 06/2014 - 04/2014
1	Therapeutics 10/2018